Home › Drug Codes › J Codes › J9264 · ABRAXANE
Updated July 1st, 2026

ABRAXANE J Code: J9264

Injection, paclitaxel protein-bound particles, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9264, effective October 1, 2026: $3.64 per HCPCS billing unit, down 44.7% from $6.586. From CMS's final file.

?
Medicare Payment Limit ?
$6.586
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$6.586
/ HCPCS billing unit · APC 1712
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
10
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, paclitaxel protein-bound particles, 1 mg
HCPCS Added Date January 1, 2006
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Suspension | Not Available

About ABRAXANE

Abraxane is a medication aligned to the HCPCS J Code: J9264 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat certain cancers (including breast, lung, and pancreatic cancer). Paclitaxel belongs to a class of drugs known as chemotherapy drugs. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 10 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00480-3290-01 Paclitaxel Teva Pharmaceuticals, Inc. 100 100 MG / 20 ML
00517-4300-01 Paclitaxel Protein Bound Particles Albumin Bound American Regent, Inc. 100 100 MG / 20 ML
00781-3531-91 Paclitaxel Sandoz Inc 100 100 MG / 20 ML
60505-6230-04 Paclitaxel Protein-Bound Apotex Corp 100 100 MG
67457-0937-50 Paclitaxel Mylan Institutional LLC 100 100 MG / 20 ML
•••••-••••-•• Log in to view ABRAXANE
ABRAXANE
ABRAXANE
Login to view 5 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ABRAXANE Pricing & Reimbursement

J9264 Private Payer Reimbursement
$9.20 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Paclitaxel 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9264 Generic Code (Multiple Manufacturers) Paclitaxel Injection, paclitaxel protein-bound particles, 1 mg
J9267 Generic Code (Multiple Manufacturers) Paclitaxel Injection, paclitaxel, 1 mg

ABRAXANE Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 13.5%
Avg. Days to File 9.6days
Avg. Days to Pay 27.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9264 claims analytics on FocalPoint →
OnPoint Oncology

ABRAXANE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Abraxane (J9264) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

ABRAXANE Medically Unlikely Edits (MUE)

The most billing units of J9264 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
800 units / day
= 800 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

ABRAXANE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Adenocarcinoma of the Pancreas Metastatic Breast Cancer Non-Small Cell Lung Cancer
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Abraxane billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for ABRAXANE.
Are there any available Abraxane patient assistance programs?
Abraxane patient assistance information can be found through Bristol Myers SquibbAccess Support at the URL: https://www.bmsaccesssupport.bmscustomerconnect.com/patient Visit Here →
Where can I find Abraxane prescribing information?
ABRAXANE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Abraxane side effect information?
Our team has not yet identified a source of side effects information for ABRAXANE. Please check back in a few weeks.
Does billing ABRAXANE require JZ/JW wastage modifiers?
CMS has identified ABRAXANE(J9264) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to ABRAXANE.

J9267PaclitaxelInjection, paclitaxel, 1 mgMultiple ManufacturersAdded January 1, 2015J9258PACLITAXEL PROTEIN-BOUND PARTICLESInjection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mgTevaAdded January 1, 2024J9259PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT)Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgAmerican RegentAdded July 1, 2023J9171DOCETAXELInjection, docetaxel, 1 mgMultiple ManufacturersAdded January 1, 2010J9174BEIZRAYInjection, docetaxel (beizray), 1 mgZydus PharmaceuticalsAdded July 1, 2025J9179HALAVENInjection, eribulin mesylate, 0.1 mgMultiple ManufacturersAdded January 1, 2012J9232DocetaxelInjection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mgMultiple ManufacturersAdded July 1, 2026J9172DOCIVYXInjection, docetaxel (docivyx), 1 mgAvyxa PharmaAdded January 1, 2024J9000ADRIAMYCINInjection, doxorubicin hydrochloride, 10 mgMultiple ManufacturersAdded January 1, 1984J9022TECENTRIQInjection, atezolizumab, 10 mgGenentechAdded January 1, 2018